Get started
000

CKD BIO CORPORATION

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

063160 chart


Full chart

Key stats


Market capitalization
‪123.43 B‬ KRW
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−100 KRW
Net income (FY)
‪−24.19 B‬ KRW
Revenue (FY)
‪160.35 B‬ KRW
Shares float
‪3.34 M‬
Beta (1Y)
0.69

Employees


Employees (FY)
500
Change (1Y)
−58 −10.39%
Revenue / Employee (1Y)
‪246.30 K‬ KRW
Net income / Employee (1Y)
‪−37.16 K‬ KRW

About CKD BIO CORPORATION


Sector
Health Technology
CEO
Jeong-Jin Lee
Headquarters
Seoul
Website
ckdbio.com
Founded
2001
ISIN
KR7063160006
FIGI
BBG000LDWB16
CKD Bio Corp. engages in the development and manufacture of active pharmaceutical ingredients. Its products include potassium clavulanate, cyclosporine, tacrolimus, demeclocycline hydrochloride, rifampicin, rifampicin SV sodium, teicoplanin, vancomycin HCL, fumagillin, diquafosol sodium, everolimus, daptomycin, tenofovir disoproxil aspartate, and acarbose. The company was founded on November 12, 2001 and is headquartered in Seoul, South Korea.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

063160 news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 063160 is 22,500 KRW — it has decreased by −0.44% in the past 24 hours. Watch CKD BIO CORPORATION stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange CKD BIO CORPORATION stocks are traded under the ticker 063160.
063160 stock has risen by 3.21% compared to the previous week, the month change is a −23.08% fall, over the last year CKD BIO CORPORATION has showed a 6.13% increase.
063160 reached its all-time high on Dec 18, 2020 with the price of 119,000 KRW, and its all-time low was 2,300 KRW and was reached on Oct 28, 2008. View more price dynamics on 063160 chart.
See other stocks reaching their highest and lowest prices.
063160 stock is 2.47% volatile and has beta coefficient of 0.69. Track CKD BIO CORPORATION stock price on the chart and check out the list of the most volatile stocks — is CKD BIO CORPORATION there?
Today CKD BIO CORPORATION has the market capitalization of ‪123.43 B‬, it has increased by 2.73% over the last week.
Yes, you can track CKD BIO CORPORATION financials in yearly and quarterly reports right on TradingView.
063160 net income for the last quarter is ‪285.22 M‬ KRW, while the quarter before that showed ‪4.40 B‬ KRW of net income which accounts for −93.52% change. Track more CKD BIO CORPORATION financial stats to get the full picture.
As of Nov 24, 2024, the company has 500.00 employees. See our rating of the largest employees — is CKD BIO CORPORATION on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CKD BIO CORPORATION EBITDA is ‪22.45 B‬ KRW, and current EBITDA margin is −1.63%. See more stats in CKD BIO CORPORATION financial statements.
Like other stocks, 063160 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CKD BIO CORPORATION stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CKD BIO CORPORATION technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CKD BIO CORPORATION stock shows the sell signal. See more of CKD BIO CORPORATION technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.